Version 5.4
Bos taurus Protein: BT.22969
Summary
InnateDB Protein IDBP-689913.2
Last Modified 2014-10-13 [Report errors or provide feedback]
Gene Symbol BT.22969
Protein Name factor XIIa inhibitor precursor
Synonyms C1NH;
Species Bos taurus
Ensembl Protein ENSBTAP00000021638
InnateDB Gene IDBG-637881 (BT.22969)
Protein Structure
UniProt Annotation
Function
Subcellular Localization
Disease Associations
Tissue Specificity
Comments
Interactions
Number of Interactions This gene and/or its encoded proteins are associated with 0 experimentally validated interaction(s) in this database.
They are also associated with 9 interaction(s) predicted by orthology.
Predicted by orthology
Total 9 [view]
Gene Ontology

Molecular Function
Accession GO Term
GO:0004867 serine-type endopeptidase inhibitor activity
GO:0005515 protein binding
Biological Process
GO:0001869 negative regulation of complement activation, lectin pathway
GO:0010951 negative regulation of endopeptidase activity
GO:0030193 regulation of blood coagulation
GO:0045916 negative regulation of complement activation
Cellular Component
GO:0005615 extracellular space
GO:0070062 extracellular vesicular exosome
GO:0072562 blood microparticle
Protein Structure and Domains
PDB ID
InterPro IPR023796 Serpin domain
PFAM PF00079
PRINTS
PIRSF
SMART SM00093
TIGRFAMs
Post-translational Modifications
Modification
Cross-References
SwissProt
PhosphoSite PhosphoSite-
TrEMBL E1BMJ0
UniProt Splice Variant
Entrez Gene 281035
UniGene Bt.22969
RefSeq NP_777246
HUGO HGNC:1228
OMIM
CCDS
HPRD
IMGT
EMBL DAAA02041763
GenPept

If you use InnateDB for your research, please cite the following publication:

Breuer et al., InnateDB: systems biology of innate immunity and beyond - recent updates and continuing curation. Nucl. Acids Res. (2013) 41 (D1) 

InnateDB is being developed jointly by the Brinkman Laboratory (Simon Fraser University, British Columbia, Canada), the Hancock Laboratory (University of British Columbia, Vancouver, British Columbia) and the Lynn EMBL Australia Group (South Australian Health & Medical Research Institute and Flinders University, Adelaide, Australia).

Funding is currently provided by Allergen and EMBL Australia. Previous funding has been provided by Genome Canada, the Foundation for the National Institutes of Health through the Grand Challenges in Global Health initiative and by Teagasc. InnateDB curated interactions are licensed under the Design Science License. All other data is licensed under the terms of the originating database. Contact: innatedb-mail@sfu.ca